PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers, and other pet supplies. It sells its products through its Internet website and mobile app; telephone contact center; and direct mail/print through catalogs, brochures, and postcards. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.
IPO Year:
Exchange: NASDAQ
Website: 1800petmeds.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/25/2023 | $20.00 | Buy | Lake Street |
| 1/25/2022 | $25.00 → $21.00 | Underweight | Morgan Stanley |
| 1/20/2022 | $32.00 | Neutral → Buy | Sidoti |
| 11/18/2021 | $25.00 | Underweight | Morgan Stanley |
| 10/1/2021 | $28.00 | Hold | Jefferies |
| 8/5/2021 | $22.00 | Underperform | Credit Suisse |
SC 13G - PETMED EXPRESS INC (0001040130) (Subject)
SC 13G - PETMED EXPRESS INC (0001040130) (Subject)
SC 13G/A - PETMED EXPRESS INC (0001040130) (Subject)
SC 13G - PETMED EXPRESS INC (0001040130) (Subject)
SC 13G/A - PETMED EXPRESS INC (0001040130) (Subject)
SC 13G/A - PETMED EXPRESS INC (0001040130) (Subject)
SC 13G - PETMED EXPRESS INC (0001040130) (Subject)
SC 13G/A - PETMED EXPRESS INC (0001040130) (Subject)
SC 13G/A - PETMED EXPRESS INC (0001040130) (Subject)
SC 13G/A - PETMED EXPRESS INC (0001040130) (Subject)
DELRAY BEACH, Fla., Jan. 07, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS), will participate in the 27th Annual ICR Conference, to be held January 13-15, 2025 in Orlando, FL. Sandra Campos, Chief Executive Officer and President, and Robyn D'Elia, Chief Financial Officer, will meet with investors and present at approximately 11:00 a.m. Eastern Time on Monday, January 13, 2025. A live webcast of the presentation will be available on the "Events & Presentations" section of PetMed's investor relations website at https://investors.petmeds.com. About PetMed Express, Inc. Founded in 1996, PetMeds is a leader in the consumer pet health
DELRAY BEACH, Fla., Dec. 03, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) ("PetMeds" or the "Company"), today announced that its Board of Directors (the "Board") has adopted a limited duration shareholder rights plan to protect the best interests of all PetMeds shareholders (the "Rights Plan"). The Board adopted the Rights Plan to protect the investment of shareholders during a period in which it believes shares of the Company do not reflect the inherent value of the business or its long-term growth potential, and during which there have been recent significant accumulations of Company common stock by certain shareholders.
Ordergroove's technology streamlines the subscription and membership experience, with ready-to-use functionalities like prepaid subscriptions, self-service management, and personalized promotions. Ordergroove, the leading technology platform that powers subscriptions for top brands and retailers, today announced a strategic partnership with PetMed Express, Inc. (NASDAQ:PETS), the original online pet pharmacy dedicated to supporting the health and well-being of four-legged family members. This collaboration marks a significant step in modernizing and scaling PetMeds + PetCareRx's (PETS) subscription and membership capabilities to maximize operational efficiency and deliver innovative and e
DELRAY BEACH, Fla., Nov. 07, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS), will participate in the Sidoti Micro Cap Conference, to be held November 13-14, 2024 virtually. Sandra Campos, CEO and President, will meet with investors and present at approximately 1:45 p.m. Eastern Time on Wednesday, November 13, 2024. A live webcast of the presentation will be available on the "Events & Presentations" section of PetMed's investor relations website at https://investors.petmeds.com or directly here. About PetMed Express, Inc. Founded in 1996, PetMeds is a leader in the consumer pet healthcare sector. As a national online retailer wit
DELRAY BEACH, Fla., Nov. 06, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its second quarter ended September 30, 2024. Second Quarter Fiscal 2025 Financial Highlights Net sales of $59.6 million.Gross margin of 29.1%, an increase of 0.8% compared to the prior year period.Net income of $2.3 million, or $0.11 per diluted share, compared to net income of $0.7 million, or $0.03 per diluted share, in the prior year period. Adjusted EBITDA of $2.1 million improved sequentially from an Adjusted EBITDA loss of $(1.5) million in the first quarter of fiscal 2025 and compared to Adjusted EBITDA of $
DELRAY BEACH, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Wednesday, November 6, 2024 at 4:30pm Eastern Time to discuss its financial results for the fiscal second quarter ended September 30, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Wednesday, November 6, 2024Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8
DELRAY BEACH, Fla., Sept. 27, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS), today announced that on September 27, 2024, PetMeds granted two equity awards previously approved by its Board of Directors to two newly hired executives as a material inducement to employment. PetMeds granted Doug Krulik, Chief Accounting Officer, 40,000 time-based restricted stock units ("RSUs") and granted Robyn D'Elia, Chief Financial Officer, 250,000 time-based RSUs. The RSUs will vest over three years in equal one-third increments on each of the first three (3) anniversaries of the grant date, subject to continued employment with the Company on eac
DELRAY BEACH, Fla., Sept. 12, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of retail and ecommerce veteran Robyn D'Elia as Chief Financial Officer ("CFO") effective September 16, 2024. D'Elia brings over 25 years of experience in financial leadership and strategic planning across multiple industries, including 24 years at Bed Bath & Beyond where she served in senior leadership roles across finance for two decades, and served as CFO from 2018 to 2020. Most recently D'Elia served as CFO at Odeko, a privately held all-in-one operations partner for independent coffee shops, cafes and ot
DELRAY BEACH, Fla., Aug. 21, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS), will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference, to be held September 4-6, 2024 in New York. Sandra Campos, CEO and President, will hold a fireside chat on September 6, 2024 at 7:45 a.m. (Eastern Time). A live audio webcast of the fireside chat will be available on the "Events & Presentations" section of PetMed's investor relations website at https://investors.petmeds.com. After the event, a replay of the fireside chat will be archived and available on this same website for approximately 90 days. About PetMed Express, Inc.
DELRAY BEACH, Fla., Aug. 06, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its first quarter ended June 30, 2024. Quarterly Highlights for Q1, Fiscal 2025 Net sales were $68 million, (13)% lower than the prior year comparable quarter.Net income was $3.8 million, or $0.18 diluted earnings per share. This compares to net loss of $(1.1) million, or $(0.06) diluted earnings per share, for the prior year comparable quarter.Increase in net income is primarily attributed to a $8.7 million reversal of accumulated stock compensation expense associated with departure of the former CEO, partially off
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
3 - PETMED EXPRESS INC (0001040130) (Issuer)
4 - PETMED EXPRESS INC (0001040130) (Issuer)
3 - PETMED EXPRESS INC (0001040130) (Issuer)
Lake Street initiated coverage of PetMed Express with a rating of Buy and set a new price target of $20.00
Morgan Stanley reiterated coverage of PetMed Express with a rating of Underweight and set a new price target of $21.00 from $25.00 previously
Sidoti upgraded PetMed Express from Neutral to Buy and set a new price target of $32.00
Morgan Stanley initiated coverage of PetMed Express with a rating of Underweight and set a new price target of $25.00
Jefferies initiated coverage of PetMed Express with a rating of Hold and set a new price target of $28.00
Credit Suisse resumed coverage of PetMed Express with a rating of Underperform and set a new price target of $22.00
Sidoti downgraded PetMed Express from Buy to Neutral and set a new price target of $39.00
Sidoti upgraded PetMed Express from Neutral to Buy
Sidoti upgraded PetMed Express from Neutral to Buy
Sidoti downgraded PetMed Express from Buy to Neutral
DELRAY BEACH, Fla., Dec. 03, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) ("PetMeds" or the "Company"), today announced that its Board of Directors (the "Board") has adopted a limited duration shareholder rights plan to protect the best interests of all PetMeds shareholders (the "Rights Plan"). The Board adopted the Rights Plan to protect the investment of shareholders during a period in which it believes shares of the Company do not reflect the inherent value of the business or its long-term growth potential, and during which there have been recent significant accumulations of Company common stock by certain shareholders.
DELRAY BEACH, Fla., Nov. 06, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its second quarter ended September 30, 2024. Second Quarter Fiscal 2025 Financial Highlights Net sales of $59.6 million.Gross margin of 29.1%, an increase of 0.8% compared to the prior year period.Net income of $2.3 million, or $0.11 per diluted share, compared to net income of $0.7 million, or $0.03 per diluted share, in the prior year period. Adjusted EBITDA of $2.1 million improved sequentially from an Adjusted EBITDA loss of $(1.5) million in the first quarter of fiscal 2025 and compared to Adjusted EBITDA of $
DELRAY BEACH, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Wednesday, November 6, 2024 at 4:30pm Eastern Time to discuss its financial results for the fiscal second quarter ended September 30, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Wednesday, November 6, 2024Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8
DELRAY BEACH, Fla., Aug. 06, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its first quarter ended June 30, 2024. Quarterly Highlights for Q1, Fiscal 2025 Net sales were $68 million, (13)% lower than the prior year comparable quarter.Net income was $3.8 million, or $0.18 diluted earnings per share. This compares to net loss of $(1.1) million, or $(0.06) diluted earnings per share, for the prior year comparable quarter.Increase in net income is primarily attributed to a $8.7 million reversal of accumulated stock compensation expense associated with departure of the former CEO, partially off
DELRAY BEACH, Fla., July 23, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Tuesday, August 6, 2024 at 4:30pm Eastern time to discuss its financial results for the fiscal first quarter ended June 30, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Tuesday, August 6, 2024Time: 4:30pm Eastern time (1:30pm Pacific time)U.S. dial-in number: 844-826-3035International number: 412-317-5195Webcast: 1Q Ear
DELRAY BEACH, Fla., June 11, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its fourth quarter and fiscal year ended March 31, 2024. Quarterly Highlights Net sales for the quarter ended March 31, 2024, were $66.5 million, compared to $62.4 million for the fourth quarter in the prior year, an increase of 6.6%, driven by the acquisition of PetCareRx partially offset by a decline in PetMeds legacy sales.Net loss for the quarter ended March 31, 2024 was $(5.0) million, or $(0.25) diluted earnings per share. This compares to net loss of $(0.2) million, or $(0.01) diluted earnings per share, for
DELRAY BEACH, Fla., May 22, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) ("PetMeds"), will hold a conference call on Tuesday, June 11, 2024 at 4:30pm Eastern time to discuss its financial results for the fourth quarter and full fiscal year ended March 31, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Tuesday, June 11, 2024Time: 4:30pm Eastern time (1:30pm Pacific time)U.S. dial-in number: 877-407-0789International number: 2
Fiscal 2024 3Q Revenue of $65.3 million, an 11% increase compared to last year including PetCareRx results.AutoShip & Save and PetPlus Membership, 52% of total revenue, up from 42% at the same time last year.Strong balance sheet with $49.4 million of cashThe Company is now current in all of its SEC filings DELRAY BEACH, Fla., April 15, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS)("PetMeds" or "Company"), Your Trusted Pet Health ExpertTM, today announced its financial results for its third quarter of fiscal year 2024, restated financial statements for the years ended March 31, 2023, 2022 and 2021, and interim financial statements for previously reported quarterly periods in
DELRAY BEACH, Fla., Feb. 08, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS) ("PetMeds" or the "Company"), Your Trusted Pet Health ExpertTM, today announced its selected preliminary financial results for its third quarter ended December 31, 2023. These preliminary financial results are unaudited, based on currently available information and do not present all necessary information for a complete understanding of the Company's financial condition as of December 31, 2023 or its results of operations for the quarter ended December 31, 2023. Quarterly Highlights Net sales for the quarter ended December 31, 2023, are expected to be $65.3 million, compared to $58.9 million for the
DELRAY BEACH, Fla., Jan. 29, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS) (the "Company"), Your Trusted Pet Health ExpertTM will hold a conference call on Thursday, February 8, 2024 at 4:30pm Eastern time to discuss its financial results for the fiscal third quarter ended December 31, 2023. Financial results will be issued in a press release prior to the call. PetMeds' management will host the conference call, followed by a question and answer period. Date: Thursday, February 8, 2024Time: 4:30pm Eastern time (1:30pm Pacific time)U.S. dial-in number: 877-407-0789 International number: 201-689-8562Webcast: 3Q Webcast Link Please call the conference telephone number 5-10 mi
DELRAY BEACH, Fla., Sept. 12, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of retail and ecommerce veteran Robyn D'Elia as Chief Financial Officer ("CFO") effective September 16, 2024. D'Elia brings over 25 years of experience in financial leadership and strategic planning across multiple industries, including 24 years at Bed Bath & Beyond where she served in senior leadership roles across finance for two decades, and served as CFO from 2018 to 2020. Most recently D'Elia served as CFO at Odeko, a privately held all-in-one operations partner for independent coffee shops, cafes and ot
DELRAY BEACH, Fla., Aug. 05, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of Doug Krulik as Chief Accounting Officer (CAO) effective August 19, 2024. Krulik comes to PetMeds with more than 20 years of leadership experience in finance and accounting, most recently with Etherio Holdings as its Vice President Finance and Controller. In this newly created role, he will oversee all aspects of the Company's accounting functions, including financial reporting, treasury, tax, compliance, and internal controls. Krulik will report directly to the Office of the Chief Financial Officer. "Doug'
Caroline Conegliano appointed Chief Operating Officer Umesh Sripad appointed Chief Digital and Technology Officer Company Announces CFO transition DELRAY BEACH, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced several changes to its executive leadership team to further advance key initiatives to improve the customer experience, and to accelerate growth and profitability. Chief Operating Officer Caroline Conegliano joins PetMeds as Chief Operating Officer (COO), in a newly created role and expansion of the executive leadership team. Ms. Conegliano brings nearly two decades of experi
DELRAY BEACH, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of Carla Dodds as Chief Marketing Officer (CMO). She brings extensive experience in leadership roles encompassing marketing, strategy and operations for major global companies including Walmart, MasterCard, Curacao, Omnilife-Chivas Group, and Penske Media Corporation. As CMO, Dodds will be responsible for leading PetMeds' integrated marketing strategy including brand and content, digital and lifecycle marketing, co-op media, customer acquisition and retention, customer insights and market research, social media
DELRAY BEACH, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., parent company of PetMeds and PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of Justin Mennen to the Company's Board of Directors ("the Board"), effective June 3, 2024. Mennen brings over 25 years of technology experience to the Company, including senior leadership roles at Rite Aid, CompuCom, Estée Lauder Companies and Dell Technologies. "Justin's vision and experience will be invaluable in advancing our digital initiatives and we are thrilled to have him join the Board," said Leslie C. G. Campbell, Chairman of the Board. "He has a strong track record of technology leadership ac
DELRAY BEACH, Fla., Jan. 8, 2024 /PRNewswire/ -- PetMed Express, Inc. ("PetMeds®") (NASDAQ:PETS), Your Trusted Pet Health Expert™, announces the appointment of Leslie C. G. Campbell as Chairman of the Board effective January 5, 2024, as part of the company's ongoing Board composition and succession planning. Ms. Campbell has served on PetMeds' Board since 2018 and will continue to serve as Chair of the Compensation Committee and a member of the Audit and Corporate Governance and Nominating Committees. Ms. Campbell previously served as Chair of the Corporate Governance and Nomi
DELRAY BEACH, Fla., May 18, 2023 (GLOBE NEWSWIRE) -- PetMed Express, Inc. ("PetMeds®") (NASDAQ:PETS), Your Trusted Pet Health Expert™, announced the appointment of Sandra Y. Campos to its Board of Directors effective May 17, 2023. "We are delighted to welcome Ms. Campos to PetMeds' board of directors," said Dr. Gian Fulgoni, Board Chairman. "Sandra's vast experience with brand management, digital transformations, and supply chain management, will undoubtedly help the Company as we continue to deliver "Nose-to-Tail" services to our pet families and continue to define the PetMeds' brand as "Your Trusted Pet Health Expert." Ms. Campos serves on the Boards of Big Lots, a nationwide retailer
Seasoned executive brings a wealth of financial leadership to further accelerate the company's digital transformation. DELRAY BEACH, Fla., July 22, 2022 /PRNewswire-PRWeb/ -- PetMed Express, Inc. (NASDAQ:PETS), Your Trusted Pet Health Expert®, announces the appointment of Christine Chambers as its Chief Financial Officer, effective on August 3. Chambers is an experienced finance professional with extensive knowledge in the digital consumer space, most recently serving as Senior Vice President, CFO and Treasurer of Seattle-based RealNetworks. Prior to that, she was Vice President, Finance at Rosetta Stone. Chambers also has served as Deputy Director, Budget and Planning at the Bill & Melinda
DELRAY BEACH, Fla., July 18, 2022 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS), Your Trusted Pet Health Expert, announces the appointment of Christine Chambers as its Chief Financial Officer, effective on August 3, 2022. Chambers is an experienced finance professional with extensive knowledge in the digital consumer space, most recently serving as Senior Vice President, CFO and Treasurer of Seattle-based RealNetworks. Prior to that, she was Vice President of Finance at Rosetta Stone. Chambers also has served as Deputy Director, Budget and Planning at the Bill & Melinda Gates Foundation. She earned an MBA from the University of Washington and a bachelor's degree in finance fr
Raj Batra, President of Siemens' Digital Industries US, Brings 20+ Years of Industrial Experience Leslie C. G. Campbell to Assume Role as Chair of the Board Shapeways, Inc. (NYSE:SHPW) ("Shapeways") a leader in the large and fast-growing digital manufacturing industry, announced today that Raj Batra has been appointed to the Company's Board of Directors ("Board") as an independent director, subject to the receipt of all applicable regulatory approvals. With 20+ years of experience in industrial automation and digitalization, Mr. Batra currently serves as President of Digital Industries (DI) for Siemens USA, where he guides the DI strategy and engagement and oversees all sales, marketing,
8-K/A - PETMED EXPRESS INC (0001040130) (Filer)
8-K - PETMED EXPRESS INC (0001040130) (Filer)
8-A12B - PETMED EXPRESS INC (0001040130) (Filer)
10-Q - PETMED EXPRESS INC (0001040130) (Filer)
8-K - PETMED EXPRESS INC (0001040130) (Filer)
8-K - PETMED EXPRESS INC (0001040130) (Filer)
S-8 - PETMED EXPRESS INC (0001040130) (Filer)
8-K - PETMED EXPRESS INC (0001040130) (Filer)
8-K - PETMED EXPRESS INC (0001040130) (Filer)
S-8 - PETMED EXPRESS INC (0001040130) (Filer)